Stock Taper 
PACB
$1.40
▼ DOWN 9.68% (-0.15)
KEY STATISTICS
Market Cap$434.84 M
52w High$2.73
52w Low$1.07
Dividend Yield—
Frequency—
P/E-3.41
Volume5.21M
Shares Out.310.60M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Mark Van Oene
COMPENSATION 2026
Salary$748,250
Stock Awards$1,151,013
Incentive Plan Pay$714,305
All Other Comp.$0
Total$4,309,846
ABOUT
SECTOR
Healthcare
WENT PUBLIC
October 27, 2010
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
485
PRICE TARGET
Target High$1.00
Target Low$1.00
Target Median$1.00
Target Consensus$1.00
UPCOMING EARNINGS
DateNov 3, 2026
DayTuesday
Rev. Est.$43.82M
NOV
3
TUE
PRICE
$1.40 ▼ DOWN 9.68% (−$0.15)About Pacific Biosciences of California, Inc.
https://www.pacb.com ↗Pacific Biosciences designs and manufactures sequencing systems and consumables for complex genetic analysis, serving research, clinical, and industrial labs worldwide through direct sales and partners.
INDUSTRY
Medical - Devices
A PRODUCT PACIFIC BIOSCIENCES OF CALIFORNIA, INC. IS KNOWN FOR
Revio system
The Revio system is a high-throughput, cost-effective long-read DNA sequencer using PacBio's SMRT technology, enabling large-scale genomic projects with highly accurate HiFi reads for applications like genome assembly and structural variant detect...
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Product | $32.6M | $38.97M ▲ | $31.53M ▼ | $32.95M ▲ |
 | Consumable | $21.28M | $21.63M ▲ | $21.81M ▲ | $20.11M ▼ |
 | Instrument | $11.32M | $17.34M ▲ | $9.72M ▼ | $12.84M ▲ |
 | Service And Other | $5.84M | $5.68M ▼ | $5.64M ▼ | $6.06M ▲ |
Revenue by Geography
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Americas | $18.1M | $20.71M ▲ | $16.68M ▼ | $17.62M ▲ |
 | EMEA | $10.75M | $14.59M ▲ | $10.77M ▼ | $14.43M ▲ |
 | Asia Pacific | $9.59M | $9.34M ▼ | $9.72M ▲ | $6.96M ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
94
LISTED HERE
15
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
56.64%
HOLDERS
359
TOP 12 OF 359 · RANKED BY POSITION SIZE
Ark Investment Management LLC
Blackrock, Inc.
Blackrock Inc.
Softbank Group Corp.
Vanguard Group Inc
Edmond De Rothschild Holding S.A.
Sumitomo Mitsui Trust Holdings, Inc.
Nikko Asset Management Americas, Inc.
Geode Capital Management, LLC
State Street Corp
Mdv Management Company, L.L.C.
Polar Capital Llp
RATINGS SNAPSHOT
Overall rating: B-
Discounted Cash Flow5
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
OFFICER: SEE REMARKS
Van Oene Mark
Sale · 26.9K shares
2026-08-17
★
OFFICER: SEE REMARKS
Van Oene Mark
Purchase · 489.1K shares
2026-08-10
★
OFFICER: SEE REMARKS
Van Oene Mark
Purchase · 2.0M shares
2026-08-10
★
DIRECTOR
MILLIGAN JOHN F
Purchase · 223.5K shares
2026-06-03
MOST RECENT ANALYST GRADES
GRADE SUMMARY
UNDERWEIGHT 1
NEUTRAL 1
OVERWEIGHT 1
3 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 IOVA | $8.01 | COMPARE |
 BFLY | $8.43 | COMPARE |
 IART | $16.89 | COMPARE |
 SIBN | $19.21 | COMPARE |
 FLGT | $19.61 | COMPARE |
 DNA | $6.96 | COMPARE |
 OFIX | $9.70 | COMPARE |
 DRIO | $6.77 | COMPARE |